Tomoko Yanai

581 citations

29 papers · 399 indexed · h-index 10

Impact in

Oncology
- Viral-associated cancers and disorders
- Cancer Cells and Metastasis
Neurology
- Neuroblastoma Research and Treatments

Papers in

Hematology 5
- Acute Myeloid Leukemia Research 2
Oncology 12
- Colorectal Cancer Treatments and Studies 3
- Viral-associated cancers and disorders 2

Co-authors: Daiichiro Hasegawa Yoshiyuki Kosaka Noriyuki Nishimura Okito Hashimoto Makiko Yoshida Yu‐ichiro Koma Hiroshi Yokozaki Akira Hayakawa
Journals: Annals of Oncology (3 papers)Japanese Journal of Clinical Oncology (2 papers)Blood (1 paper)Environmental Health and Preventive Medicine (1 paper)Journal of Pediatric Hematology/Oncology (1 paper)
Partner nations: Japan United States Taiwan

In The Last Decade

Tomoko Yanai

28 papers receiving 390 citations

Peers

Countries citing papers authored by Tomoko Yanai

Since Specialization

Citations

This map shows the geographic impact of Tomoko Yanai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Yanai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Yanai more than expected).

Fields of papers citing papers by Tomoko Yanai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Yanai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Yanai. The network helps show where Tomoko Yanai may publish in the future.

Co-authors

The 25 scholars most cited alongside Tomoko Yanai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tomoko Yanai Line = papers co-authored together Tomoko Yanai links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study Cancer Research Communications ·Yasutoshi Kuboki, Toshio Shimizu, Kan Yonemori, Takashi Kojima, Shunsuke Kondo, Shigehiro Koganemaru, Satoru Iwasa, Kenichi Harano, Takafumi Koyama, Vickie Lu, Xiaofei Zhou, Huifeng Niu, Tomoko Yanai, Ignacio Garcia‐Ribas, Toshihiko Doi, Noboru Yamamoto	2022	7
2	A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies Targeted Oncology ·Toshio Shimizu, Yasutoshi Kuboki, Chia‐Chi Lin, Kan Yonemori, Tomoko Yanai, Douglas V. Faller, lwona Dobler, Neeraj Gupta, Farhad Sedarati, Kyu‐pyo Kim	2021	5
3	Hematopoietic Stem Cell Transplantation and Brentuximab Vedotin for Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large-Cell Lymphoma Advances in Therapy ·Kenichi Ishizawa, Tomoko Yanai	2019	2
4	J-FORCE study: A randomized, double-blind, placebo-controlled phase III study evaluating olanzapine (5 mg) combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based, highly emetogenic chemotherapy Annals of Oncology ·Hiroki Hashimoto, Satoru Iwasa, Masakazu Abé, Tomoko Yanai, Sadamoto Zenda, Takuhiro Yamaguchi, Harumi Kaba, Hiroyuki Fukuda, Hiroyuki Terakado, Y. Ohe	2017	1
5	Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients Oncology Letters ·Satoshi Hirase, Atsuro Saitoh, Tri Budi Hartomo, Aiko Kozaki, Tomoko Yanai, Daiichiro Hasegawa, Keiichiro Kawasaki, Yoshiyuki Kosaka, Masafumi Matsuo, Nobuyuki Yamamoto, Takeshi Mori, Akira Hayakawa, Kazumoto Iijima, Hisahide Nishio, Noriyuki Nishimura	2016	13
6	Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients Oncology Letters ·Nobuyuki Yamamoto, Aiko Kozaki, Tri Budi Hartomo, Tomoko Yanai, Daiichiro Hasegawa, Keiichiro Kawasaki, Yoshiyuki Kosaka, Masafumi Matsuo, Satoshi Hirase, Takeshi Mori, Akira Hayakawa, Kazumoto Iijima, Hisahide Nishio, Noriyuki Nishimura	2015	8
7	Sterility Testing of Stem Cell Products by Broad-Range Bacterial 16S Ribosomal DNA Polymerase Chain Reaction Laboratory Medicine ·Osamu Tokuno, Akira Hayakawa, Tomoko Yanai, Takeshi Mori, Kenichiro Ohnuma, Ayumi Tani, Hironobu Minami, Takeshi Sugimoto	2015	11
8	Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia International Journal of Hematology ·Satoshi Hirase, Daiichiro Hasegawa, Hironobu Takahashi, Kensuke Moriwaki, Atsuro Saito, Aiko Kozaki, Toshiaki Ishida, Tomoko Yanai, Keiichiro Kawasaki, Nobuyuki Yamamoto, Ikuko Kubokawa, Takeshi Mori, Akira Hayakawa, Noriyuki Nishimura, Hisahide Nishio, Kazumoto Iijima, Yoshiyuki Kosaka	2015	5
9	A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy Japanese Journal of Clinical Oncology ·Kengo Nagashima, Satoru Iwasa, Tomoko Yanai, Hiroki Hashimoto, Kenichi Suzuki, F. Ohyanagi, Yasuhiro Shimada, Noboru Yamamoto	2014	9
10	The first report of adolescent TAFRO syndrome, a unique clinicopathologic variant of multicentric Castleman’s disease BMC Pediatrics ·Ikuko Kubokawa, Akihiro Yachie, Akira Hayakawa, Satoshi Hirase, Nobuyuki Yamamoto, Takeshi Mori, Tomoko Yanai, Yasuhiro Takeshima, Eiryu Kyo, Goichi Kageyama, Hiroshi Nagai, Keiichiro Uehara, Masaru Kojima, Kazumoto Iijima	2014	48
11	The emergence of CD20−/CD19− tumor cells after rituximab therapy for Epstein–Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis European Journal of Pediatrics ·Nobuyuki Yamamoto, Noriyuki Nishimura, Mai Takeuchi, Tomoo Ito, Hiroshi Yokozaki, Satoshi Hirase, Ikuko Kubokawa, Takeshi Mori, Tomoko Yanai, Akira Hayakawa, Yasuhiro Takeshima, Hisahide Nishio, Masafumi Matsuo, Ken‐Ichi Imadome, Kazumoto Iijima	2013	5
12	A Double-blind, Placebo-controlled Study of the Safety and Efficacy of Vitamin K1 Ointment for the Treatment of Patients with Cetuximab-induced Acneiform Eruption Japanese Journal of Clinical Oncology ·Hironobu Hashimoto, Satoru Iwasa, Tomoko Yanai, Yoshitaka Honma, Ken Kato, Tsuyoshi Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada, Kenjiro Namikawa, Arata Tsutsumida, Naoya Yamazaki, Hisashi Yamamoto	2012	4
13	Place of death of pediatric cancer patients in a single institute during 7 years. PubMed ·Tomoko Yanai, Satoshi Hirase, Natsuki Matsunoshita, Nobuyuki Yamamoto, Takeshi Ninchoji, Ikuko Kubokawa, Takeshi Mori, Akira Hayakawa, Yasuhiro Takeshima, Kazumoto Iijima, Masafumi Matsuo	2012	4
14	Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections Drugs in R&D ·Y Kanda, Tomoko Kayama, Shinji Okamoto, Masako Hashimoto, Chiemi Ishida, Tomoko Yanai, Mitsuru Fukumoto, Eiichi Kunihiro	2012	5
15	Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells Environmental Health and Preventive Medicine ·Noriyuki Nishimura, Tri Budi Hartomo, Thi Van Pham, Myeong Jin Lee, Tomoto Yamamoto, Satoru Morikawa, Daiichiro Hasegawa, Hiroki Takeda, Keiichiro Kawasaki, Yoshiyuki Kosaka, Nobuyuki Yamamoto, Ikuko Kubokawa, Takeshi Mori, Tomoko Yanai, Akira Hayakawa, Yasuhiro Takeshima, Kazumoto Iijima, Masafumi Matsuo, Hisahide Nishio	2011	27
16	Prophylactic administration of epinephrine in oxaliplatin-related hypersensitivity reaction. Journal of Clinical Oncology ·Satoru Iwasa, Tsuyoshi Hamaguchi, Kooichi Tada, Tomoko Yanai, Hirhonobu Hashimoto, T Nakajima, Ken Kato, Yasuhide Yamada, Yasuhiro Shimada	2011	2
17	ASSOCIATION OF GENETIC POLYMORPHISMS WITH HEPATOTOXICITY IN PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOMA Pediatric Hematology and Oncology ·Masanori Horinouchi, Mariko Yagi, Hiroyuki Imanishi, Takeshi Mori, Tomoko Yanai, Akira Hayakawa, Yasuhiro Takeshima, Michiyo Hijioka, Noboru Okamura, Toshiyuki Sakaeda, Masafumi Matsuo, Katsuhiko Okumura, Tsutomu Nakamura	2010	17
18	Persistent detection of a novel MLL–SACM1L rearrangement in the absence of leukemia Leukemia Research ·Takeshi Mori, Noriyuki Nishimura, Daiichiro Hasegawa, Keiichiro Kawasaki, Yoshiyuki Kosaka, Kazuko Uchide, Tomoko Yanai, Akira Hayakawa, Yasuhiro Takeshima, Hisahide Nishio, Masafumi Matsuo	2010	5
19	Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients Transfusion and Apheresis Science ·Katsuyasu Saigo, Yasuyuki Sakota, Yukako Masuda, Kyoko Matsunaga, Mariko Takenokuchi, Kunihiro Nishimura, T Sugimoto, Kosuke Sakurai, Makoto Hashimoto, Tomoko Yanai, Akira Hayakawa, Yasuhiro Takeshima, Tsutomu Nomura, Yoshitsugu Kubota, Shunichi Kumagai	2008	36
20	High Level of Ezrin mRNA Expression in an Osteosarcoma Biopsy Sample With Lung Metastasis Journal of Pediatric Hematology/Oncology ·Wakako Ogino, Yasuhiro Takeshima, Takeshi Mori, Tomoko Yanai, Akira Hayakawa, Toshihiro Akisue, Masahiro Kurosaka, Masafumi Matsuo	2007	16

About Tomoko Yanai

Tomoko Yanai is a scholar working on Hematology, Oncology, Neurology, Internal Medicine and Pediatrics, Perinatology and Child Health, having authored 29 papers that have together received 399 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), Nausea and vomiting management (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer therapeutics and mechanisms (3 papers), Acute Myeloid Leukemia Research (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Oncology (174 citations), Neurology (91 citations), Hematology (52 citations), Immunology (93 citations) and Cancer Research (58 citations). Tomoko Yanai has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Daiichiro Hasegawa, Yoshiyuki Kosaka, Noriyuki Nishimura, Okito Hashimoto, Makiko Yoshida, Yu‐ichiro Koma, Hiroshi Yokozaki, Akira Hayakawa, Yasuhiro Takeshima and Takeshi Mori. Their work appears in journals such as Annals of Oncology, Japanese Journal of Clinical Oncology, Blood, Environmental Health and Preventive Medicine and Journal of Pediatric Hematology/Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact